Moderna Therapeutics

Moderna Therapeutics

TRIA provided architectural services for Moderna Therapeutics’ new $110 million, 200,000 SF GMP mRNA clinical manufacturing facility. TRIA designed clinical labs, offices, employee facilities, and a conference center. Construction of the new facility completed in mid-2018. Moderna will carry out all manufacturing activities at the site, from raw material production to active pharmaceutical ingredients (APIs), formulation, filling and finish.

DPS provided full architectural and engineering design for Moderna’s Norwood facility and also provided construction management oversight, commissioning, qualification & validation, and procurement services.

Project Genetics

  • Ample amenities support employee engagement
  • Transparency between office and lab

Project Location

Norwood, Mass.

Project Size

200,000 SF

Project Completion

2018

Project Type

Facility renovation

TRIA provided architectural services for Moderna Therapeutics’ new $110 million, 200,000 SF GMP mRNA clinical manufacturing facility. TRIA designed clinical labs, offices, employee facilities, and a conference center. Construction of the new facility completed in mid-2018. Moderna will carry out all manufacturing activities at the site, from raw material production to active pharmaceutical ingredients (APIs), formulation, filling and finish.

DPS provided full architectural and engineering design for Moderna’s Norwood facility and also provided construction management oversight, commissioning, qualification & validation, and procurement services.